Skip to main content

Incident Use of Rivaroxaban

    Basic Details
    Date Posted
    Wednesday, March 7, 2018
    Medical Product

    This report investigates exposure to rivaroxaban among all patients in the Mini-Sentinel Distributed Database (MSDD) and among members with a pre-existing condition of atrial fibrillation and atrial flutter. Data from July 1, 2011 to September 30, 2013 from 18 Data Partners contributing to the MSDD were included in this request. The request was distributed to Data Partners on November 22, 2013.

    Additional Details
    FDA Center
    Time Period
    July 1, 2011 - September 30, 2013
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)